Unknown

Dataset Information

0

Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.

ABSTRACT:

SUBMITTER: Bala MM 

PROVIDER: S-EPMC6513409 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
| S-EPMC6464540 | biostudies-literature
Unknown Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
| S-EPMC8094585 | biostudies-literature
Unknown Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
| S-EPMC6485894 | biostudies-literature
Unknown Prevention of thrombosis in antiphospholipid syndrome.
| S-EPMC6142449 | biostudies-literature
Unknown Antiplatelet agents for stroke prevention.
| S-EPMC3250274 | biostudies-literature
Unknown Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents.
| S-EPMC5198250 | biostudies-other
Unknown Antiplatelet agents for the treatment of deep venous thrombosis
| S-EPMC6457577 | biostudies-literature
Unknown Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.
| S-EPMC6536697 | biostudies-literature
Unknown Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents.
| S-EPMC3283221 | biostudies-literature
Unknown The Trilogy of SARS-CoV-2 in Pediatrics (Part 3): Thrombosis, Anticoagulant, and Antiplatelet Considerations.
| S-EPMC8372867 | biostudies-literature